Are Berkeley Group Holdings plc, Whitbread plc and Mediclinic International plc the 3 hottest stocks on the FTSE 100?

Should you pile into these 3 stocks right now? Berkeley Group Holdings plc (LON: BKG), Whitbread plc (LON: WTB) and Mediclinic International plc (LON: MDC).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Whitbread (LSE: WTB) had been a hugely reliable growth play prior to a year ago. In fact, its shares had risen by 285% in the five years from May 2010 to May 2015. However, since then its shares have dropped by almost a quarter as investors have become increasingly concerned about the company’s growth prospects and valuation.

In terms of its growth potential, Whitbread is facing a rather uncertain future. That’s because its cost base is rapidly rising as the living wage causes staff costs to increase and while Whitbread apparently intends to pass such increased costs onto consumers, this could hurt its sales and profitability. Regarding its valuation, Whitbread now trades on a price-to-earnings (P/E) ratio of 15.8 which, given its forecast growth in earnings of 4% for the current year, may appear to be somewhat high.

However, with Whitbread’s earnings growth due to return to a much more encouraging 10% next year, it trades on a price-to-earnings-growth (PEG) ratio of only 1.5. This indicates that while its future is somewhat uncertain, Whitbread has a sufficiently wide margin of safety to merit investment at the present time.

The uncertainty principle

Similarly, the outlook for Berkeley (LSE: BKG) is also uncertain. The UK housing market appears to be expensive compared to historical levels, with the price-to-buyer income ratio being close to its highest-ever level. And with there being the potential for a Brexit next month, Berkeley’s sales could come under pressure as foreign investors look for better value and potentially more security elsewhere.

However, with Berkeley forecast to increase its bottom line by as much as 51% in the current financial year, investor sentiment could rapidly improve in the coming months. That’s especially the case since Berkeley trades on a P/E ratio of just 11.2, which indicates that its shares could deliver a major upward rerating in the medium-to-long term. So, while Berkeley isn’t risk-free, its potential rewards appear to outweigh its risks and this makes it a sound long-term buy.

The diversity dividend

Meanwhile, Mediclinic (LSE: MDC) offers excellent long-term growth prospects, with its operations in Southern Africa and the Middle East in particular having the potential to boost its top and bottom lines. In addition, Mediclinic’s Swiss exposure provides it with additional diversity that could be a useful ally during a period of uncertainty for the world economy.

Looking ahead, Mediclinic is forecast to increase its bottom line by 30% in the current year and by a further 12% next year. This puts it on a PEG ratio of just 0.7 and this shows that while the company’s shares have fallen by 21% since the start of the year, there’s plenty of scope for a reversal of this performance over the medium-to-long term. And with Mediclinic having a beta of just 0.7, it offers a potentially less volatile shareholder experience, too.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of Berkeley Group Holdings. The Motley Fool UK has recommended Berkeley Group Holdings. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »

Investing Articles

Investing £5 a day could help me build a second income of £329 a month!

This Fool explains how £5 a day, or one less takeaway coffee, could help her build a monthly second income…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

2 FTSE income stocks investors should consider buying in April

Income stocks are a great way to build wealth. Our writer details two picks she believes investors should consider snapping…

Read more »

Investing Articles

What might the 5-year price chart tell us about BT shares?

Christopher Ruane considers what clues the long-term performance of BT shares might offer him about business performance and whether to…

Read more »